Previous close | 0.9199 |
Open | 0.9300 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.9200 - 0.9800 |
52-week range | 0.7300 - 11.9000 |
Volume | |
Avg. volume | 67,070 |
Market cap | 20.035M |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to review 2024 first quarter results.
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023.
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m. Eastern Time to review 2023 fourth quarter and full year results.